©The Author(s) 2015.
World J Gastroenterol. Jan 7, 2015; 21(1): 318-325
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.318
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.318
Table 4 Management strategies for the intestinal obstruction in the study group
| Type of treatment | n (%) |
| Conservative | 45 (75.0) |
| Gastrografin PO | 15 (33.3) |
| Enema | 12 (26.6) |
| Combination of Gastrografin PO + enema and/or Gastrografin enema and/or N-acetylcysteine PO | 11 (24.4) |
| Gastrografin enema | 4 (8.8) |
| N-acetylcysteine enema | 3 (6.6) |
| Surgical | 11 (18.3) |
| Laparotomy with milking | 3 (27.2) |
| Other | 8 (72.7) |
| No intervention | 4 (6.6) |
| Total | 60 (100) |
| Supportive | 37 (61.6) |
| Antibiotics | 10 (27.0) |
| IV fluids | 13 (35.1) |
| Feeding tube | 6 (16.2) |
| Peglax | 6 (16.2) |
| Laxatives | 2 (5.4) |
- Citation: Lavie M, Manovitz T, Vilozni D, Levy-Mendelovich S, Sarouk I, Weintraubv I, Shoseyov D, Cohen-Cymberknoh M, Rivlin J, Efrati O. Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis. World J Gastroenterol 2015; 21(1): 318-325
- URL: https://www.wjgnet.com/1007-9327/full/v21/i1/318.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i1.318